{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:20:54Z","timestamp":1760188854776},"reference-count":13,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2006,7,20]],"date-time":"2006-07-20T00:00:00Z","timestamp":1153353600000},"content-version":"vor","delay-in-days":6775,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Prostate"],"published-print":{"date-parts":[[1988,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Since 1981 we have been studying prostate cancer (Pca) by mass screening in three cities, eight towns and seven villages in Gunma prefecture, Japan. From 1981 to 1985, 5,770 subjects were examined. The clinical character of Pea detected by mass screening is compared with control (i.e., Pca detected in the outpatient clinic in Gunma University). Of the 54 Pca patients detected by mass screening (Stage B: 28, C: 8, D: 18), approximately 50% had early\u2010stage Pca. The ratio of early\u2010stage Pca is significantly higher than in the control. An extended survival rate in high\u2010stage Pca detected by mass screening also was observed through comparison with control. We determined two types of Pca in advanced stage: (1) asymptomatic or less symptomatic and better prognostic Pca found in mass screening and (2) symptomatic and worse prognostic Pca found in control.<\/jats:p>","DOI":"10.1002\/pros.2990120303","type":"journal-article","created":{"date-parts":[[2007,2,21]],"date-time":"2007-02-21T01:08:37Z","timestamp":1172020117000},"page":"199-207","source":"Crossref","is-referenced-by-count":23,"title":["Clinical characteristics of prostatic cancer detected by mass screening"],"prefix":"10.1002","volume":"12","author":[{"given":"Kyoichi","family":"Imai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Zinbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamon","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuminari","family":"Kumasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zin","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,20]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"1464","volume-title":"Campbell's Urology","author":"Catalona WJ","year":"1986"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(81)90072-8"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)52915-8"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(86)90276-1"},{"key":"e_1_2_1_6_2","first-page":"293","article-title":"Studies on prostatic cancer. I. The effect of castration and estrogen and of androgen injection on the serum phosphatase in metastatic carcinoma of the prostate","volume":"1","author":"Huggins C","year":"1943","journal-title":"Cancer Res"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(86)90275-X"},{"key":"e_1_2_1_8_2","unstructured":"WHO Handbook for Reporting Results of Cancer Treatment. WHO Offset Publication No. 48 Geneva 1979."},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.2974\/kmj1951.37.179"},{"key":"e_1_2_1_10_2","volume-title":"Prostate Cancer","author":"Catalona WJ","year":"1984"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19850701)56:1<173::AID-CNCR2820560127>3.0.CO;2-0"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)49828-4"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1984.03350230021025"},{"key":"e_1_2_1_14_2","first-page":"606","article-title":"The problems and future of mass screening for prostate cancer","volume":"30","author":"Watanabe H","year":"1984","journal-title":"Gan"}],"container-title":["The Prostate"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpros.2990120303","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pros.2990120303","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T13:50:13Z","timestamp":1697896213000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pros.2990120303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,1]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1988,1]]}},"alternative-id":["10.1002\/pros.2990120303"],"URL":"https:\/\/doi.org\/10.1002\/pros.2990120303","archive":["Portico"],"relation":{},"ISSN":["0270-4137","1097-0045"],"issn-type":[{"value":"0270-4137","type":"print"},{"value":"1097-0045","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,1]]}}}